PCT and Invetech experts lead webinar on Building Deliverable Cell Therapeutics for ISCT

ISCT hosted a webinar, titled "Building Deliverable Cell Therapeutics: A Methodical Approach to Manufacturing Development," featuring experts from PCT on October 22, 2014 about processes and methods that are integral for the development and commercialization of cell therapies from a manufacturing perspective. A recording of the webinar can be accessed here.

Session Chair:

Robert Shaw, Vice President, Commercial Development of PCT

Speakers:

Brian Hampson, Vice President, Manufacturing Development & Engineering of PCT
Richard Grant, Director, Cell Therapy of Invetech

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH are all now operating under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.

PCT and Invetech experts lead webinar on Building Deliverable Cell Therapeutics for ISCT

Stay up to date on the latest cell therapy industry insights

Related Articles

PCT Celebrates 20 Years of ISCT

Executive Interview - PCT: Manufacturing the Future of Cell Therapies

Reducing Idle Capacity Through the Factory of the Future

Subscribe to Our Email Distribution List